Sign In
Manage PermissionsManage Permissions

FIVE Health Products Found Adulterated

‚ÄčHEALTH PRODUCTS FOUND ADULTERATED 

The Ministry of Health would like to alert members of the public to five types of health products which have been tested by the Pharmacy Section, Department of Scientific Services, Ministry of Health and found to be adulterated with undeclared, potent western medicines.

The affected health products are listed as below:                                            

No.Name of productManufacturerAdulterated with
1.Ginseng Kianpi PilUnknownDexamethasone & Cyproheptadine
2.Urat Saraf KapsulProduk Industri Kampung, MalaysiaDexamethasone & Diclofenac
3.Montalin Jamu Pegal Linu dan Asam Urat KapsulPJ.Air Madu, IndonesiaCyproheptadine
4.Jamu Caissar Raja Obat Kuat KapsulPJ.Sinar Bulan, IndonesiaSildenafil
5.Hammer of Thor 850mg CapsuleMade in ItalySildenafil

 

The adulterants found in these products can cause adverse effects that are potentially hazardous to the people using them.

Unsupervised long-term consumption of potent corticosteroids such as Dexamethasone can cause increase blood glucose levels leading to diabetes, high blood pressure, cataract, muscular and bone disorders, and an increased risk of infections. Long term use of corticosteroids can also lead to Cushing's syndrome which is characterized by a round face or 'moon face', and upper body obesity with thin limbs. Consumers who have taken high doses of steroids over a prolonged period of time may suffer from withdrawal symptoms which include fatigue, muscle and joint pain, fever, low blood sugar, low blood pressure and dehydration.

Cyproheptadine is antihistamines used in the treatment of allergies symptoms. If taken without supervision it can cause drowsiness, dizziness, muscle weakness, hypotension, blurred vision, dry mouth, depression, arrhythmias, increase in appetite and weight gain.

Diclofenac is a pain-relief medicine that, if taken without supervision, may result in peptic ulceration, gastrointestinal bleeding, nausea, vomiting, skin rashes, blurred vision, oedema, jaundice and kidney failure.

Sildenafil is a drug used to treat male impotency and can only be prescribed by a qualified doctor or physician. Among their side effects include nausea, vomiting, flushing and dizziness. In severe cases, they can also result in abnormal increase in heart rate, sudden loss of hearing and seizures.

The Ministry of Health has not issued any approval for the importation for the sale of these products. Following these findings, the products are not allowed to be imported and sold in Brunei Darussalam.

Members of the public who have purchased or used these products are advised to stop using them immediately. They should also consult a medical practitioner if they feel unwell or experience any undesirable reactions as a result of using them.

Members of the public involved in the retail of these products (including online retail such as through Facebook, etc.) are hereby reminded that it is an offence under the Poisons Act 1956 to sell any product containing any substance controlled under the said Act and the penalty for such an offence upon conviction, is a fine of $8,000 or six months' imprisonment. Furthermore, if a person commits an Act that amounts to such a degree of negligence so as to endanger or be likely to endanger human life, then such person shall be guilty of an offence which carries a penalty of a fine of $16,000 and 12 months' imprisonment.

The Ministry of Health would also like to call upon the public for their cooperation to report to the Compliance and Licensing Section if any of these products are still found on the market in this country.

For further information and communication, the public may contact the Compliance and Licensing Section at 2393298 extension 208; send an e-mail to pharmacy.enforcement@moh.gov.bn; go directly to 1st Floor, Compliance and Licensing Section, Department of Pharmaceutical Services' Building, Kg. Madaras, Mukim Gadong A; or call the Talian Darussalam 123.

 

- E N D -

 

Reference : KK/PR/3

Date           : 24 January 2019 / 18 Jamadilawal 1440H


Attachments